Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.
2.

A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.

Kootstra JJ, Dijkstra PU, Rietman H, de Vries J, Baas P, Geertzen JH, Hoekstra HJ, Hoekstra-Weebers JE.

Breast Cancer Res Treat. 2013 May;139(1):125-34. doi: 10.1007/s10549-013-2509-y. Epub 2013 Apr 16.

PMID:
23588950
3.

Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.

Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ.

Ann Surg Oncol. 2004 Nov;11(11):1018-24. Epub 2004 Oct 15.

PMID:
15525832
4.

Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.

Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ.

Cancer. 2003 Aug 15;98(4):690-6. Erratum in: Cancer. Cancer. 2004 May 1;100(9):1991.

5.

Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.

McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ.

J Clin Oncol. 2008 Nov 10;26(32):5213-9. doi: 10.1200/JCO.2008.16.3725. Epub 2008 Oct 6. Erratum in: J Clin Oncol. 2010 Apr 1;28(10):1808.

6.

The Perioperative Educational Program for Improving Upper Arm Dysfunction in Patients with Breast Cancer at 1-Year Follow-Up: A Prospective, Controlled Trial.

Sato F, Arinaga Y, Sato N, Ishida T, Ohuchi N.

Tohoku J Exp Med. 2016;238(3):229-36. doi: 10.1620/tjem.238.229.

7.

A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.

Kootstra JJ, Hoekstra-Weebers JE, Rietman JS, de Vries J, Baas PC, Geertzen JH, Hoekstra HJ.

Ann Surg Oncol. 2010 Sep;17(9):2384-94. doi: 10.1245/s10434-010-0981-8. Epub 2010 Mar 11.

8.

Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.

Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA.

Arch Phys Med Rehabil. 2014 May;95(5):875-81. doi: 10.1016/j.apmr.2013.12.015. Epub 2014 Jan 2.

PMID:
24389401
9.

Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.

Helms G, Kühn T, Moser L, Remmel E, Kreienberg R.

Eur J Surg Oncol. 2009 Jul;35(7):696-701. doi: 10.1016/j.ejso.2008.06.013. Epub 2008 Oct 5.

PMID:
18838245
10.

Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.

Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU.

Eur J Surg Oncol. 2006 Mar;32(2):148-52. Epub 2006 Jan 4.

PMID:
16387467
11.

Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.

McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ.

J Clin Oncol. 2008 Nov 10;26(32):5220-6. doi: 10.1200/JCO.2008.16.3766. Epub 2008 Oct 6.

12.

Arm lymphoedema after axillary surgery in women with invasive breast cancer.

Sackey H, Magnuson A, Sandelin K, Liljegren G, Bergkvist L, Fülep Z, Celebioglu F, Frisell J.

Br J Surg. 2014 Mar;101(4):390-7. doi: 10.1002/bjs.9401.

PMID:
24536010
13.

Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.

Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.

Lymphology. 2004 Jun;37(2):73-91.

PMID:
15328760
14.

Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.

Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE.

Ann Surg Oncol. 2008 Jul;15(7):1996-2005. doi: 10.1245/s10434-008-9909-y. Epub 2008 Apr 16.

PMID:
18415650
15.

Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.

Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC.

Am J Surg. 2002 Jan;183(1):23-7.

PMID:
11869698
16.

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.

Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW.

J Clin Oncol. 2005 Jul 1;23(19):4312-21.

17.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
18.
19.

Sentinel node biopsy and quality of life measures in a Chinese population.

Chen JJ, Huang XY, Liu ZB, Chen TW, Cheng JY, Yang WT, Xu WP, Shao ZM, Shen ZZ, Wu J.

Eur J Surg Oncol. 2009 Sep;35(9):921-7. doi: 10.1016/j.ejso.2009.01.009. Epub 2009 Feb 23.

PMID:
19233602
20.

Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.

Sackey H, Johansson H, Sandelin K, Liljegren G, MacLean G, Frisell J, Brandberg Y.

Eur J Surg Oncol. 2015 Apr;41(4):577-84. doi: 10.1016/j.ejso.2014.12.006. Epub 2015 Jan 13.

PMID:
25659877
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk